Data sources

Source-labeled psilocybin and psilocin literature for search, monitoring, export, and citation workflows.

How the research index is built

Eight research sources feed Psilocybin-Research.com PubMed, OpenAlex, Crossref, Europe PMC, ClinicalTrials.gov, PsyArXiv, bioRxiv, and medRxiv provide records that are reconciled into the central research index. psilocybin-research.com PubMed OpenAlex Crossref Europe PMC ClinicalTrials.gov PsyArXiv bioRxiv medRxiv
Source records are fetched, reconciled, and labeled before appearing in the live index. The original sources remain authoritative.

Research workflow

Search, filter, export, analyze, and monitor publications with source labels, publication status, citation links, alerts, API access, and a rights-safe SQLite download. Read about the methods and limitations. Explore the dataset and reuse guide or research trends by year.

Paper citation network

A living systematic review, meta-analysis and open-data resource of randomized controlled trials of psilocybin treatment for symptoms of depression

Singleton S. Parker, Sevchik Brooke L., Lahey Analiese, Cuijpers Pim, Harrer Mathias, Jones Megan T., Nayak Sandeep M., Strain Eric C., Vandekar Simon N., Dworkin Robert H., Scott J. Cobb, Satterthwaite Theodore D.

Publication record · Explore literature

Public tracker catalogue and stored structured reference metadata. External references may have identifiers only. No live external citation lookup is performed.

References — this paper cites (65)

  1. Psilocybin for major depressive disorder: An updated systematic review and meta-analysis of randomized clinical trials. 2026-01-01 · Expand citations
  2. Psilocybin-assisted group psychotherapy and mindfulness-based stress reduction for frontline healthcare provider COVID-19-related depression and burnout: A randomized controlled trial. 2025-09-01 · Expand citations
  3. Psilocybin in alcohol use disorder and comorbid depressive symptoms: Results from a feasibility randomized clinical trial. 2025-07-24 · Expand citations
  4. Control Group Outcomes in Trials of Psilocybin, SSRIs, or Esketamine for Depression: A Meta-Analysis. 2025-07-01 · Expand citations
  5. Randomized Controlled Trials of Psilocybin-Assisted Therapy in the Treatment of Major Depressive Disorder: Systematic Review and Meta-Analysis. 2025-05-01 · Expand citations
  6. Psilocybin-assisted psychotherapy for depression and anxiety associated with life threatening illness: A phase 2b randomized controlled trial. 2025-01-01 · Expand citations
  7. Quality of reporting on psychological interventions in psychedelic treatments: a systematic review. 2025-01-01 · Expand citations
  8. Psilocybin Therapy for Clinicians With Symptoms of Depression From Frontline Care During the COVID-19 Pandemic: A Randomized Clinical Trial. 2024-12-02 · Expand citations
  9. Comparative oral monotherapy of psilocybin, lysergic acid diethylamide, 3,4-methylenedioxymethamphetamine, ayahuasca, and escitalopram for depressive symptoms: systematic review and Bayesian network meta-analysis. 2024-08-21 · Expand citations
  10. Efficacy of psilocybin for treating symptoms of depression: systematic review and meta-analysis. 2024-05-01 · Expand citations
  11. Psilocybin-assisted psychotherapy for treatment resistant depression: A randomized clinical trial evaluating repeated doses of psilocybin. 2024-03-08 · Expand citations
  12. Psilocybin, an Effective Treatment for Major Depressive Disorder in Adults - A Systematic Review. 2024-02-29 · Expand citations
  13. Efficacy and acceptability of psilocybin for primary or secondary depression: A systematic review and meta-analysis of randomized controlled trials. 2024-01-01 · Expand citations
  14. Is Poorly Assisted Psilocybin Treatment an Increasing Risk? 2024-01-01 · Expand citations
  15. Misinterpretations and Omissions: A Critical Response to Goodwin and Colleagues' Commentary on Psilocybin-Assisted Therapy. 2024-01-01 · Expand citations
  16. Must Psilocybin Always "Assist Psychotherapy"? 2024-01-01 · Expand citations
  17. Psilocybin Without Psychotherapy: A Cart Without a Horse? 2024-01-01 · Expand citations
  18. Psilocybin for major depressive disorder: a systematic review of randomized controlled studies. 2024-01-01 · Expand citations
  19. Psychological Support for Psilocybin Treatment: Reply to Letters on Our Commentary. 2024-01-01 · Expand citations
  20. Psychotherapy in Psychedelic Treatment: Safe, Evidence-Based, and Necessary 2024-01-01 · Expand citations
  21. The Promise of Therapeutic Psilocybin: An Evaluation of the 134 Clinical Trials, 54 Potential Indications, and 0 Marketing Approvals on ClinicalTrials.gov. 2024-01-01 · Expand citations
  22. Psilocybin-assisted therapy for depression: A systematic review and meta-analysis. 2023-11-01 · Expand citations
  23. Single-Dose Psilocybin Treatment for Major Depressive Disorder: A Randomized Clinical Trial. 2023-09-05 · Expand citations
  24. Psychotherapy with Psilocybin for Depression: Systematic Review. 2023-03-31 · Expand citations
  25. Psychedelic therapy for depressive symptoms: A systematic review and meta-analysis. 2023-02-01 · Expand citations
  26. Single-dose psilocybin-assisted therapy in major depressive disorder: A placebo-controlled, double-blind, randomised clinical trial. 2023-02-01 · Expand citations
  27. Psychedelic Drug Legislative Reform and Legalization in the US. 2023-01-01 · Expand citations
  28. Single-Dose Psilocybin for a Treatment-Resistant Episode of Major Depression. 2022-11-03 · Expand citations
  29. Expectancy in placebo-controlled trials of psychedelics: if so, so what? 2022-10-01 · Expand citations
  30. Effects of Psilocybin-Assisted Therapy on Major Depressive Disorder: A Randomized Clinical Trial. 2021-05-01 · Expand citations
  31. Trial of Psilocybin versus Escitalopram for Depression. 2021-04-15 · Expand citations
  32. Psychedelic Psychiatry's Brave New World. 2020-04-02 · Expand citations
  33. Psilocybin produces substantial and sustained decreases in depression and anxiety in patients with life-threatening cancer: A randomized double-blind trial. 2016-12-01 · Expand citations
  34. Rapid and sustained symptom reduction following psilocybin treatment for anxiety and depression in patients with life-threatening cancer: a randomized controlled trial. 2016-12-01 · Expand citations
  35. Pilot study of psilocybin treatment for anxiety in patients with advanced-stage cancer. 2011-01-01 · Expand citations
  36. 10.1001/archpsyc.1984.01790140028003
  37. 10.1001/archpsyc.64.4.419
  38. 10.1001/jamapsychiatry.2025.4809
  39. 10.1002/jrsm.1475
  40. 10.1002/sim.1482
  41. 10.1002/sim.2514
  42. 10.1007/s11121-021-01246-3
  43. 10.1007/s11920-007-0061-3
  44. 10.1007/s40273-021-01040-7
  45. 10.1016/j.eclinm.2025.103149
  46. 10.1038/s41386-023-01755-5
  47. 10.1038/s44220-024-00373-4
  48. 10.1056/nejmoa051688
  49. 10.1080/17512433.2021.1951473
  50. 10.1136/bmj.315.7109.629
  51. 10.1136/ebmental-2019-300117
  52. 10.1176/ajp.2006.163.4.611
  53. 10.1176/appi.ajp.163.1.28
  54. 10.1176/appi.ajp.20230643
  55. 10.1176/appi.ajp.20230667
  56. 10.1177/070674371005500304
  57. 10.1177/20451253231198466
  58. 10.18637/jss.v036.i03
  59. 10.18637/jss.v093.i06
  60. 10.3102/10769986030003261
  61. 10.31234/osf.io/7tbrm
  62. 10.31234/osf.io/caup9_v1
  63. 10.4088/jcp.20m13699
  64. 10.5281/zenodo.15714852
  65. 10.6028/jres.087.022

Cited by — these papers cite this paper (4)

  1. Psilocybin in Treatment-Resistant Depression: Weighing Rapid Antidepressant Effects Against Uncertain Durability 2026-10-19 · Expand citations
  2. Ayahuasca and Salvia divinorum as contrasting modes of consciousness reorganization: Implications for psychedelic-assisted psychotherapy 2026-08-13 · Expand citations
  3. Psilocybin-Assisted Therapy in Psychiatry: A Narrative Clinical Review of Mechanisms, Therapeutic Applications, and Emerging Evidence (2025-2026) 2026-08-12 · Expand citations
  4. Past-Year Psilocybin and Alcohol Co-Use: Associations With Mental Health Symptoms 2026-07-01 · Expand citations